| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 08/13/2009 | WO2009099086A1 3-substituted sulfonyl piperazine derivative |
| 08/13/2009 | WO2009098908A1 Novel hydroxy radical generation method, and anti-viral material utilizing hydroxy radical generated by the method |
| 08/13/2009 | WO2009098901A1 3,8-diaminotetrahydroquinoline derivative |
| 08/13/2009 | WO2009098870A1 Dental sterilizing water, method for producing the water, and device for producing the water |
| 08/13/2009 | WO2009098786A1 Antiviral material, environment-friendly antiviral material and antiviral material packed in packaging material |
| 08/13/2009 | WO2009098400A1 Compound of the disaccharide type composition comprising and method for producing such a compound |
| 08/13/2009 | WO2009098320A2 Macrolides for treating diseases mediated through pde inhibition |
| 08/13/2009 | WO2009098206A1 Molecules comprising a bis(heteroaryl)maleimide backbone, and use thereof in the inhibition of dde/ddd enzymes |
| 08/13/2009 | WO2009097863A1 Auto vaccination for hiv+ve patients, auto haemotherapy for aids disease |
| 08/13/2009 | WO2009097682A1 Anti-influenza compounds |
| 08/13/2009 | WO2009097670A1 Combination of immunomodulator and anti-pathogenic agent |
| 08/13/2009 | WO2009097651A1 Methods and compositions for treating inflammatory bowel disease |
| 08/13/2009 | WO2009077485A3 1(2)h-tetrazol-5-yl-phenyl-oxazolidinones as antibacterial agents |
| 08/13/2009 | WO2009076321A3 Compositions and methods for modulating gene expression using asymmetrically-active precursor polynucleotides |
| 08/13/2009 | WO2009043525A3 Use of the combination of gluten exorphin c and cd36 as a therapeutic agent |
| 08/13/2009 | WO2009043477A3 Use of glpl (7-36) alone or in combination with leptin 22-56 as a therapeutic agent |
| 08/13/2009 | WO2009043453A3 Use of a peptide as a therapeutic agent |
| 08/13/2009 | WO2009043436A3 Use of af12198 as a therapeutic agent |
| 08/13/2009 | WO2009040031A3 Use of a peptide as a therapeutic agent |
| 08/13/2009 | WO2009039991A3 Use of aviptadil as a therapeutic agent |
| 08/13/2009 | WO2009039964A3 Use of glucagon-like peptide as a therapeutic agent |
| 08/13/2009 | WO2009037538A3 Process for the preparation of lamivudine form i |
| 08/13/2009 | WO2009033792A3 Gamma 1 msh alone or in combination with pentagastrin as a therapeutic agent |
| 08/13/2009 | WO2009031043A3 Compositions comprising yersinia pestis antigens |
| 08/13/2009 | WO2009005798A3 Antifungal formulation and method of preparation |
| 08/13/2009 | WO2009001217A3 Low-additive influenza vaccines |
| 08/13/2009 | WO2008031104A3 Antimicrobial compositions and related applications |
| 08/13/2009 | US20090203890 Hepatitis c antivirals |
| 08/13/2009 | US20090203878 Tryptophan as a functional replacement for adp-ribose-arginine in recombinant proteins |
| 08/13/2009 | US20090203798 Solid Pharmaceutical Compositions Comprising a SIP Receptor Agonist and a Sugar Alcohol |
| 08/13/2009 | US20090203797 Antimycotic Patch |
| 08/13/2009 | US20090203775 Novel compound and a novel microorganism for producing the novel compound |
| 08/13/2009 | US20090203767 Inhibition stat-1 |
| 08/13/2009 | US20090203754 Anti-bacterial drug targeting of genome maintenance interfaces |
| 08/13/2009 | US20090203751 Novel 1,2,4-thiadiazolium derivatives as melanocortin receptor modulators |
| 08/13/2009 | US20090203743 Small molecule entry inhibitors |
| 08/13/2009 | US20090203742 Broadspectrum 2-amino-benzothiazole sulfonamide hiv protease inhibitors |
| 08/13/2009 | US20090203739 Anti-Inflammatory Agents |
| 08/13/2009 | US20090203730 Bicyclic ppat inhibitors as antibacterial agents |
| 08/13/2009 | US20090203726 Substituted tetrahydroquinolines as antibacterial agents |
| 08/13/2009 | US20090203698 Compounds for Enzyme Inhibition |
| 08/13/2009 | US20090203694 Inhibitors of undecaprenyl pyrophosphate synthase |
| 08/13/2009 | US20090203631 Peptide deformylase inhibitors as novel antibiotics |
| 08/13/2009 | US20090203630 Process for preparing atazanavir bisulfate and novel forms |
| 08/13/2009 | US20090203615 Use of activity dependent neurotrophic factor for enhancing learning and memory: pre-and post-natal administration |
| 08/13/2009 | US20090203600 Pharmaceutical composition for the prophylaxis and treatment of hiv infection and its use |
| 08/13/2009 | US20090203585 Capreomycin derivatives and their use as antibacterials |
| 08/13/2009 | US20090203583 Use of Type-B Lantibiotic-Based Compounds having Antimicrobial Activity |
| 08/13/2009 | US20090203582 Lysobactin amides |
| 08/13/2009 | US20090203144 Hiv-gag codon-optimised dna vaccines |
| 08/13/2009 | US20090203114 Novel methods and interferon deficient substrates for the propagation of viruses |
| 08/13/2009 | US20090203028 Novel aptamers that bind to listeria surface proteins |
| 08/13/2009 | US20090202663 Pharmaceutical composition for the treatment of otomycosis |
| 08/13/2009 | US20090202651 Antigen specific fluorescent nanoparticles |
| 08/13/2009 | US20090202615 Compositions for Treating Biofilms and Methods for Using Same |
| 08/13/2009 | US20090202601 Method for inhibiting onset of or treating pollen allergy |
| 08/13/2009 | US20090202594 Anti-bacterial Vaccine Compositions |
| 08/13/2009 | US20090202590 Influenza vaccines extemporaneously adsorbed to aluminium adjuvants |
| 08/13/2009 | US20090202589 Fermenter system for biotechnical processes |
| 08/13/2009 | US20090202588 Nucleic acids encoding TGEV and PRRSV sequences for improved expression of PRRSV sequences |
| 08/13/2009 | US20090202578 Surface proteins from coagulase-negative staphylococci and staphylococcus aureus that generate cross-reactive monoclonal and polyclonal antibodies |
| 08/13/2009 | US20090202575 Immunostimulatory nucleic acid molecules |
| 08/13/2009 | US20090202553 Antibodies against anthrax protective antigen |
| 08/13/2009 | US20090202496 Method for regenerating an immune system |
| 08/13/2009 | US20090202492 Adenovirus vaccine utilizing ikk as adjuvant |
| 08/13/2009 | US20090202486 Difluorinated tripeptides as hcv serine protease inhibitors |
| 08/13/2009 | US20090202485 Heteroaryl-containing tripeptide hcv serine protease inhibitors |
| 08/13/2009 | US20090202483 Hepatitis C Virus Inhibitors |
| 08/13/2009 | US20090202482 Prevention and Treatment of HCV Infection Employing Antibodies Directed Against Conformational and Linear Epitopes |
| 08/13/2009 | US20090202477 Methods of treating infections using il-21 |
| 08/13/2009 | US20090202476 Crystalline forms of n-(tert-butoxycarbonyl)-3-methyl-l-valyl-(4r)-4-((7-chloro-4-methoxy-1-isoquinolinyl)oxy)-n-((1r,2s)-1-((cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)-l-prolinamide |
| 08/13/2009 | US20090202475 Compositions and methods for treatment of microbial disorders |
| 08/13/2009 | US20090202470 Phosphonate Analogs of Hiv Inhibitor Compounds |
| 08/13/2009 | US20090202463 Antimicrobial compositions, products and methods employing same |
| 08/13/2009 | US20090202452 Oral care regimen |
| 08/13/2009 | US20090202440 Model animal of dendritic cell immunoreceptor gene knockout disease |
| 08/13/2009 | US20090202430 Composition for cytocompatible, injectable, self-gelling polysaccharide solutions for encapsulating and delivering live cells or biologically active factors |
| 08/13/2009 | DE102008007440A1 Aminosäurederivate als Arzneistoffe Amino acid derivatives as drugs |
| 08/13/2009 | DE102008007381A1 Amidine und Guanidine und deren Derivate zur Behandlung von Krankheiten Amidines and guanidines and their derivatives for the treatment of diseases |
| 08/13/2009 | CA2715483A1 Molecules comprising a bis(heteroaryl)maleimide backbone, and use thereof in the inhibition of dde/ddd enzymes |
| 08/13/2009 | CA2715266A1 Inhibition and treatment of gastrointestinal biofilms |
| 08/13/2009 | CA2715140A1 Novel hydroxy radical generation method, and anti-viral material utilizing hydroxyl radical generated by the method |
| 08/13/2009 | CA2714480A1 3,8-diaminotetrahydroquinoline derivative |
| 08/13/2009 | CA2714478A1 Dental sterilizing water, method for producing the water, and device for producing the water |
| 08/13/2009 | CA2714389A1 Macrolides and uses of macrolides |
| 08/13/2009 | CA2714282A1 Conjugated molecules comprising a peptide derived from the cd4 receptor coupled to a polyanion for the treatment of aids |
| 08/13/2009 | CA2714043A1 Methods and compositions for treating inflammatory bowel disease |
| 08/13/2009 | CA2713933A1 Camptothecin-binding moiety conjugates |
| 08/13/2009 | CA2713848A1 Anti-influenza compounds |
| 08/13/2009 | CA2712971A1 Macrocyclic serine protease inhibitors |
| 08/13/2009 | CA2711399A1 3-substituted sulfonylpiperidine derivative |
| 08/12/2009 | EP2088197A2 Haemophilus influenzae antigens and corresponding DNA fragments |
| 08/12/2009 | EP2088158A2 Monoclonal antibody against the CCR5 chemokine receptor |
| 08/12/2009 | EP2088152A1 N'-{n-[3-oxo-lupen-28-oyl]-9-aminononanoyl}-3-amino-3-phenylpropeonic acid and the pharmaceutically acceptable derivatives thereof, a method for the production and the use thereof in the form of a medicinal agent |
| 08/12/2009 | EP2088143A1 Novel inhibitors of mycobacterium tuberculosis complex cytochrome P450 CYP121 |
| 08/12/2009 | EP2087907A2 Method and system to remove cytokine inhibitor in patients |
| 08/12/2009 | EP2087906A1 Proteins expressed by Mycobacterium tuberculosis and not by BCG and their use as diagnostic reagents and vaccines |
| 08/12/2009 | EP2087899A1 Grifola frondosa-origin substance having antiinfluenza virus activity and method of producing the same |
| 08/12/2009 | EP2087891A2 Pharmaceutical compositions for treating lymphoma |
| 08/12/2009 | EP2087004A2 A novel passive vaccine for candida infections |